JP2020532288A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532288A5
JP2020532288A5 JP2020501311A JP2020501311A JP2020532288A5 JP 2020532288 A5 JP2020532288 A5 JP 2020532288A5 JP 2020501311 A JP2020501311 A JP 2020501311A JP 2020501311 A JP2020501311 A JP 2020501311A JP 2020532288 A5 JP2020532288 A5 JP 2020532288A5
Authority
JP
Japan
Prior art keywords
collection
expression vectors
nucleic acids
acids according
entire
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020501311A
Other languages
English (en)
Japanese (ja)
Other versions
JP7274223B2 (ja
JP2020532288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/069032 external-priority patent/WO2019012082A1/en
Publication of JP2020532288A publication Critical patent/JP2020532288A/ja
Publication of JP2020532288A5 publication Critical patent/JP2020532288A5/ja
Application granted granted Critical
Publication of JP7274223B2 publication Critical patent/JP7274223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020501311A 2017-07-12 2018-07-12 マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン Active JP7274223B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17181026.0 2017-07-12
EP17181026 2017-07-12
PCT/EP2018/069032 WO2019012082A1 (en) 2017-07-12 2018-07-12 UNIVERSAL VACCINE BASED ON SHARED TUMOR NEO-ANTIGENS FOR THE PREVENTION AND TREATMENT OF MICRO-SATELLITE INSTABILITY CANCER (MSI)

Publications (3)

Publication Number Publication Date
JP2020532288A JP2020532288A (ja) 2020-11-12
JP2020532288A5 true JP2020532288A5 (OSRAM) 2021-08-05
JP7274223B2 JP7274223B2 (ja) 2023-05-16

Family

ID=59366234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020501311A Active JP7274223B2 (ja) 2017-07-12 2018-07-12 マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン

Country Status (19)

Country Link
US (1) US11578109B2 (OSRAM)
EP (1) EP3652606B1 (OSRAM)
JP (1) JP7274223B2 (OSRAM)
KR (1) KR102709778B1 (OSRAM)
CN (1) CN111328420B (OSRAM)
AU (1) AU2018298849B2 (OSRAM)
BR (1) BR112020000590A2 (OSRAM)
CA (1) CA3069047A1 (OSRAM)
DK (1) DK3652606T5 (OSRAM)
ES (1) ES2940087T3 (OSRAM)
FI (1) FI3652606T3 (OSRAM)
HU (1) HUE061840T2 (OSRAM)
IL (1) IL271966B2 (OSRAM)
MX (1) MX2020000413A (OSRAM)
NZ (1) NZ759940A (OSRAM)
PL (1) PL3652606T3 (OSRAM)
PT (1) PT3652606T (OSRAM)
SG (1) SG11202000250PA (OSRAM)
WO (1) WO2019012082A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3827263A1 (en) 2018-07-26 2021-06-02 Frame Pharmaceuticals B.V. Cancer vaccines for colorectal cancer
WO2020022903A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER
CA3106567A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. Cancer vaccines for kidney cancer
EP3827261A1 (en) 2018-07-26 2021-06-02 Frame Pharmaceuticals B.V. Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
US20210187088A1 (en) 2018-07-26 2021-06-24 Frame Pharmaceuticals B.V. Cancer vaccines for uterine cancer
CA3106564A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. Cancer vaccines for breast cancer
TWI852977B (zh) 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
US20220008525A1 (en) * 2019-02-07 2022-01-13 Arizona Board Of Regents On Behalf Of Arizona State University Cancer specific frameshift vaccines
IL293051A (en) 2019-11-18 2022-07-01 Janssen Biotech Inc Vaccines based on mutant calr and jak2 and their uses
WO2021228999A1 (en) * 2020-05-12 2021-11-18 Institut Curie Neoantigenic epitopes associated with sf3b1 mutations
US12295997B2 (en) 2020-07-06 2025-05-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
JP2024516542A (ja) * 2021-04-06 2024-04-16 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム Mhcクラスiペプチドを含む方法および組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922315A (en) 1997-01-24 1999-07-13 Genetic Therapy, Inc. Adenoviruses having altered hexon proteins
WO2003087162A2 (en) * 2002-04-18 2003-10-23 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer
US20060160090A1 (en) * 2003-04-11 2006-07-20 Macina Robert A Composition splice variants and methods relating to cancer specific genes and proteins
CN1824325A (zh) * 2005-12-16 2006-08-30 武汉大学 人乳头病毒dna嵌合疫苗及制备方法和应用
KR101454287B1 (ko) * 2006-10-17 2014-11-04 온코세라피 사이언스 가부시키가이샤 Mphosph1 또는 depdc1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
TW201102081A (en) * 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
SG175407A1 (en) 2009-05-29 2011-11-28 Morphosys Ag A collection and methods for its use
JP2013523084A (ja) * 2010-04-09 2013-06-17 オンコセラピー・サイエンス株式会社 Cdca5ペプチドおよびそれを含むワクチン
CA2830787C (en) * 2011-03-24 2019-11-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dominant negative hsp110 mutant and its use in prognosing and treating cancers
DK2742133T3 (en) * 2011-08-12 2017-12-04 Oncotherapy Science Inc MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
BR112015013737B1 (pt) * 2012-12-13 2021-07-27 Ruprecht-Karls-Universitãt Heidelberg Peptídeos com alteração do quadro de leitura msiespecífico (fsp) para a prevenção e tratamento do câncer
US9205140B2 (en) * 2012-12-13 2015-12-08 Ruprecht-Karls-Universität MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
JP5890769B2 (ja) * 2012-12-13 2016-03-22 ループレヒト−カルルス・ウニヴェルジテート・ハイデルベルクRuprecht−Karls−Universitaet Heidelberg がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)
WO2014099979A2 (en) * 2012-12-17 2014-06-26 Virginia Tech Intellectual Properties, Inc. Methods and compositions for identifying global microsatellite instability and for characterizing informative microsatellite loci
WO2015112930A1 (en) * 2014-01-27 2015-07-30 Yale University Novel methods of identifying patients responsive to immunotherapeutic strategies
IL302102A (en) 2015-05-20 2023-06-01 Dana Farber Cancer Inst Inc shared neoantigens
CN106350578A (zh) * 2015-07-13 2017-01-25 中国人民解放军第二军医大学 Ny-eso-1在微卫星不稳定性肠癌的诊断和治疗中的应用
US12150980B2 (en) * 2015-07-30 2024-11-26 Modernatx, Inc. Concatemeric peptide epitope RNAs

Similar Documents

Publication Publication Date Title
JP2020532288A5 (OSRAM)
JP2017140920A5 (OSRAM)
JP2020054657A5 (OSRAM)
JP2019533243A5 (OSRAM)
JP2019520713A5 (OSRAM)
JP2017157543A5 (OSRAM)
JP2017194540A5 (OSRAM)
JP2022077837A5 (OSRAM)
RU2018108575A (ru) Применение гвоздя в качестве заклёпки
TH178712S (th) ของเล่น
TH178708S (th) ของเล่น
TH69691S1 (th) ของเล่น
TH71956S1 (th) ของเล่น
TH71957S1 (th) ของเล่น
TH178707S (th) ของเล่น
TH69688S1 (th) ของเล่น
TH178709S (th) ของเล่น
TH69685S1 (th) ของเล่น
TH69684S1 (th) ของเล่น
TH178710S (th) ของเล่น
TH69689S1 (th) ของเล่น
TH183551S (th) ของเล่น
TH71254S1 (th) หลอดดูด
TH174182S (th) หลอดดูด
TH69690S1 (th) ของเล่น